JP2009221205A5 - - Google Patents

Download PDF

Info

Publication number
JP2009221205A5
JP2009221205A5 JP2009110392A JP2009110392A JP2009221205A5 JP 2009221205 A5 JP2009221205 A5 JP 2009221205A5 JP 2009110392 A JP2009110392 A JP 2009110392A JP 2009110392 A JP2009110392 A JP 2009110392A JP 2009221205 A5 JP2009221205 A5 JP 2009221205A5
Authority
JP
Japan
Prior art keywords
indole
carboxamide
morpholin
sulfonyl
bromo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009110392A
Other languages
English (en)
Japanese (ja)
Other versions
JP5261275B2 (ja
JP2009221205A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2009221205A publication Critical patent/JP2009221205A/ja
Publication of JP2009221205A5 publication Critical patent/JP2009221205A5/ja
Application granted granted Critical
Publication of JP5261275B2 publication Critical patent/JP5261275B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2009110392A 2002-08-09 2009-04-30 チロシンキナーゼ阻害薬 Expired - Fee Related JP5261275B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40247802P 2002-08-09 2002-08-09
US60/402,478 2002-08-09

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2004527799A Division JP4332112B2 (ja) 2002-08-09 2003-08-05 チロシンキナーゼ阻害薬

Publications (3)

Publication Number Publication Date
JP2009221205A JP2009221205A (ja) 2009-10-01
JP2009221205A5 true JP2009221205A5 (https=) 2009-11-26
JP5261275B2 JP5261275B2 (ja) 2013-08-14

Family

ID=31715862

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2004527799A Expired - Fee Related JP4332112B2 (ja) 2002-08-09 2003-08-05 チロシンキナーゼ阻害薬
JP2009110392A Expired - Fee Related JP5261275B2 (ja) 2002-08-09 2009-04-30 チロシンキナーゼ阻害薬

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2004527799A Expired - Fee Related JP4332112B2 (ja) 2002-08-09 2003-08-05 チロシンキナーゼ阻害薬

Country Status (8)

Country Link
US (2) US7560546B2 (https=)
EP (1) EP1534695B1 (https=)
JP (2) JP4332112B2 (https=)
AT (1) ATE482938T1 (https=)
AU (1) AU2003261415C1 (https=)
CA (1) CA2494962C (https=)
DE (1) DE60334386D1 (https=)
WO (1) WO2004014851A2 (https=)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003261415C1 (en) * 2002-08-09 2010-01-14 Merck Sharp & Dohme Corp. Tyrosine kinase inhibitors
WO2004014300A2 (en) * 2002-08-09 2004-02-19 Merck & Co., Inc. Tyrosine kinase inhibitors
SE0302811D0 (sv) * 2003-10-23 2003-10-23 Astrazeneca Ab Novel compounds
JO2724B1 (en) 2004-08-19 2013-09-15 افينتس فارماسوتيكالز انك 3-Alternative-5 -6-Amino Alkyl Indole-2-Carboxyl Acid Amide and Related Isotopes as Casein Kinase Inhibitors
US8957070B2 (en) 2005-04-20 2015-02-17 Takeda Pharmaceutical Company Limited Glucokinase activator compounds, methods of activating glucokinase and methods of treating diabetes and obesity
AU2006262016A1 (en) * 2005-06-28 2007-01-04 Merck & Co., Inc. Non-nucleoside reverse transcriptase inhibitors
AR055343A1 (es) * 2005-06-30 2007-08-22 Smithkline Beecham Corp Derivados de indolcarboxamida inhibidores de quinasas ikk2
US20090131494A1 (en) * 2005-08-11 2009-05-21 Williams Theresa M Non-Nucleoside Reverse Transcriptase Inhibitors
EP2123644B1 (en) 2007-03-07 2014-12-17 Takeda Pharmaceutical Company Limited Benzoxazepine derivatives and use thereof
US8642067B2 (en) 2007-04-02 2014-02-04 Allergen, Inc. Methods and compositions for intraocular administration to treat ocular conditions
CA2758071C (en) 2009-04-06 2018-01-09 Agios Pharmaceuticals, Inc. Pyruvate kinase m2 modulators, therapeutic compositions and related methods of use
WO2010138490A1 (en) * 2009-05-26 2010-12-02 Exelixis, Inc. Benzoxazepines as inhibitors of mtor and methods of their use and manufacture
ES2618630T3 (es) * 2009-06-29 2017-06-21 Agios Pharmaceuticals, Inc. Composiciones terapéuticas y métodos de uso relacionados
TWI598337B (zh) 2009-06-29 2017-09-11 阿吉歐斯製藥公司 治療化合物及組成物
WO2012083246A1 (en) 2010-12-17 2012-06-21 Agios Pharmaceuticals, Inc. Novel n- (4- (azetidine - 1 - carbonyl) phenyl) - (hetero - ) arylsulfonamide derivatives as pyruvate kinase m2 (pmk2) modulators
ES2569712T3 (es) 2010-12-21 2016-05-12 Agios Pharmaceuticals, Inc. Activadores de PKM2 bicíclicos
TWI549947B (zh) 2010-12-29 2016-09-21 阿吉歐斯製藥公司 治療化合物及組成物
AU2012245971A1 (en) * 2011-04-21 2013-10-17 Piramal Enterprises Limited A crystalline form of a salt of a morpholino sulfonyl indole derivative and a process for its preparation
SMT202400081T1 (it) 2011-05-03 2024-03-13 Agios Pharmaceuticals Inc Attivatori della piruvato chinasi per uso in terapia
US9181231B2 (en) 2011-05-03 2015-11-10 Agios Pharmaceuticals, Inc Pyruvate kinase activators for use for increasing lifetime of the red blood cells and treating anemia
US8748446B2 (en) 2012-03-03 2014-06-10 Nanoquantum Sciences, Inc. Halogenated compounds for photodynamic therapy
US20150119394A1 (en) * 2012-03-28 2015-04-30 Merck Sharp & Dohme Corp. Insulin-Like Growth Factor-1 Receptor Inhibitors
DK2970265T3 (en) * 2013-03-15 2018-10-01 Plexxikon Inc HETEROCYCLIC COMPOUNDS AND APPLICATIONS THEREOF
WO2014139144A1 (en) 2013-03-15 2014-09-18 Agios Pharmaceuticals, Inc. Therapeutic compounds and compositions
US20140303121A1 (en) 2013-03-15 2014-10-09 Plexxikon Inc. Heterocyclic compounds and uses thereof
CA2989111C (en) 2015-06-11 2023-10-03 Agios Pharmaceuticals, Inc. Methods of using pyruvate kinase activators
US10717735B2 (en) 2017-10-13 2020-07-21 Plexxikon Inc. Solid forms of a compound for modulating kinases
US20250340532A1 (en) * 2022-06-02 2025-11-06 Xizang Haisco Pharmaceutical Co., Ltd. Heterocyclic compound ccr4 inhibitor and user thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3209011A (en) * 1963-10-07 1965-09-28 Upjohn Co 3-[(alkylcarbamoyl) sulfamoyl]-1-alkylindole-2-carboxylic acids and esters thereof
FR1410699A (fr) 1963-10-07 1965-09-10 Upjohn Co Nouveaux indols
US3180875A (en) * 1963-10-07 1965-04-27 Upjohn Co Derivatives of 3, 3'-dithiobis[indole-2-carboxylic acid] dihydrazides
BR8204028A (pt) 1981-07-16 1983-07-05 Du Pont Composto herbicida composicao adequada e processo para controlar o crescimento de vegetacao indesejada
US5527819A (en) * 1991-09-06 1996-06-18 Merck & Co., Inc. Inhibitors of HIV reverse transcriptase
CN1119856A (zh) * 1993-02-24 1996-04-03 麦克公司 Hiv逆转录酶抑制剂
ATE243203T1 (de) 1995-04-04 2003-07-15 Texas Biotechnology Corp Thienyl-, furyl-, pyrrolyl- und biphenylsulfonamide und derivate zur modulation der endothelin-aktivität
JP2002511852A (ja) * 1997-05-07 2002-04-16 スージェン・インコーポレーテッド 蛋白質キナーゼ活性の調節剤としての2−インドリノン誘導体
GB9902455D0 (en) * 1999-02-05 1999-03-24 Zeneca Ltd Chemical compounds
WO2003035621A1 (en) 2001-10-22 2003-05-01 The Research Foundation Of State University Of New York Protein kinase and phosphatase inhibitors, methods for designing them, and methods of using them
WO2004014300A2 (en) 2002-08-09 2004-02-19 Merck & Co., Inc. Tyrosine kinase inhibitors
AU2003261415C1 (en) * 2002-08-09 2010-01-14 Merck Sharp & Dohme Corp. Tyrosine kinase inhibitors

Similar Documents

Publication Publication Date Title
JP2009221205A5 (https=)
CA2494962A1 (en) Tyrosine kinase inhibitors
JP4684229B2 (ja) ヘテロアリール置換された1,3−ジヒドロインドール−2−オン誘導体および該誘導体を含有する医薬品
RU2007117913A (ru) 2, 6-замещенные-4-монозамещенный амино-пиримидины как антагонисты рецептора простагландина d2
RU2482111C2 (ru) Соединения, обладающие противораковой активностью
JP2013517273A5 (https=)
RU2009103313A (ru) Индолы в качестве модуляторов 5-нт6
AU732863B2 (en) Indole derivatives having combined 5HT1A, 5HT1B and 5HT1D receptor antagonist activity
PE20090717A1 (es) Derivados de quinolina como inhibidores de la pi3 quinasa
JP2013544840A5 (https=)
JP2010513304A5 (https=)
RU2006129492A (ru) Производные индола и их применение в качестве ингибиторов киназ, в частности, ингибиторов ikk2
US20040127536A1 (en) Methods for treating an inflammatory condition or inhibiting JNK
RU2010137114A (ru) Амидные производные как позитивные аллостерические модуляторы и способы их применения
JP2010529991A5 (https=)
RU2006117635A (ru) Производные индолинона и их применение для лечения патологических состояний, таких как злокачественное новообразование
JP2007516173A5 (https=)
PE20080944A1 (es) Derivados de pirimidina como inhibidores del receptor de cinasa activina(alk-5)
JP2006505522A5 (https=)
RU2013133800A (ru) Селективные к bcl-2 агенты, вызывающие апоптоз, для лечения рака и иммунных заболеваний
JP2004521087A5 (https=)
JP2008500320A5 (https=)
JP2005531501A5 (https=)
CN1345318A (zh) 与多巴胺d3受体具有亲和力的三唑化合物
JP2014514299A5 (https=)